These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34901221)
1. Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry. Lee OH; Kim Y; Cho DK; Kim JS; Kim BK; Choi D; Hong MK; Jeong MH; Jang Y; Front Cardiovasc Med; 2021; 8():762090. PubMed ID: 34901221 [No Abstract] [Full Text] [Related]
2. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760 [TBL] [Abstract][Full Text] [Related]
3. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK; Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621 [TBL] [Abstract][Full Text] [Related]
4. Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. Park J; Choi EK; Han KD; Choi YJ; Lee E; Choe W; Lee SR; Cha MJ; Lim WH; Kang J; Park KW; Oh S; Lip GYH PLoS One; 2019; 14(1):e0209593. PubMed ID: 30645601 [TBL] [Abstract][Full Text] [Related]
5. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
7. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention. Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357 [TBL] [Abstract][Full Text] [Related]
8. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP; JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation. Wu Y; Liu H; Qin L; Wang Y; Zhang S; Wang Z; Zou Y; Yin T Front Cardiovasc Med; 2022; 9():923684. PubMed ID: 35845074 [TBL] [Abstract][Full Text] [Related]
10. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981 [TBL] [Abstract][Full Text] [Related]
11. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology. Fukamachi D; Hirayama A; Miyauchi K; Yasuda S; Ogawa H; Ito H; Daida H J Cardiol; 2018 Aug; 72(2):113-119. PubMed ID: 29599096 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk? Fake AL; Harding SA; Matsis PP; Larsen PD N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167 [TBL] [Abstract][Full Text] [Related]
14. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry. Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443 [TBL] [Abstract][Full Text] [Related]
15. Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients. Galli M; Andreotti F; Porto I; Crea F Europace; 2020 Apr; 22(4):538-546. PubMed ID: 31942971 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Stenestrand U; Lindbäck J; Wallentin L; Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376 [TBL] [Abstract][Full Text] [Related]
18. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy. Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39). Ho CY; Nunn C; White J; Kerr A; Lee M N Z Med J; 2020 Jul; 133(1519):41-54. PubMed ID: 32777794 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland. Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]